Cyclerion Therapeutics, Inc. (CYCN) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 1.02M | 875K | 93K | 81K | 1.81M | 194K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 306K | 711K | 533K | 348K | 3M |
| Revenue Growth % | -100% | -43.24% | 351.03% | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -89.8% | 1046.77% | 300.75% | -13% | 300.53% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 339K | 572K | 776K | 0 | 10.22M | 9.74M | 10.46M | 7.03M | 12.05M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3339.22% | 1370.32% | 1962.1% | 2020.69% | 401.8% |
| Gross Profit | 0 | 1.02M | 875K | 93K | 81K | 1.81M | 194K | 0 | 0 | 0 | 0 | -339K | -572K | -776K | 0 | -9.91M | -9.03M | -9.93M | -6.68M | -9.05M |
| Gross Margin % | - | 100% | 100% | 100% | 100% | 100% | 100% | - | - | - | - | - | - | - | - | -3239.22% | -1270.32% | -1862.1% | -1920.69% | -301.8% |
| Gross Profit Growth % | -100% | -43.24% | 351.03% | - | - | - | - | 100% | 100% | 100% | - | 96.58% | 93.67% | 92.18% | 100% | -9.48% | -14667.74% | 17.01% | 49.76% | -1308.81% |
| Operating Expenses | 3.21M | 1.86M | 1.88M | 1.76M | 1.54M | 1.3M | 1.32M | 1.38M | 1.62M | 1.79M | 6.01M | 1.53M | 2.7M | 3.68M | 4.52M | 3.52M | 3.95M | 4.41M | 4.6M | 7.12M |
| OpEx % of Revenue | - | 181.76% | 214.97% | 1897.85% | 1898.77% | 72.2% | 681.44% | - | - | - | - | - | - | - | - | 1150.65% | 555.84% | 827.96% | 1322.13% | 237.4% |
| Selling, General & Admin | 2.48M | 1.34M | 1.53M | 1.71M | 1.5M | 1.25M | 1.24M | 1.28M | 1.57M | 1.97M | 2.13M | 1.53M | 2.7M | 3.68M | 3.1M | 3.52M | 3.95M | 4.41M | 4.6M | 6.24M |
| SG&A % of Revenue | - | 131.12% | 175.2% | 1837.63% | 1854.32% | 69.1% | 639.69% | - | - | - | - | - | - | - | - | 1150.65% | 555.84% | 827.96% | 1322.13% | 208.03% |
| Research & Development | 730K | 519K | 348K | 56K | 36K | 56K | 81K | 105K | 44K | 24K | 580K | 339K | 572K | 1.18M | 1.41M | 10.22M | 9.74M | 10.46M | 7.03M | 12.05M |
| R&D % of Revenue | - | 50.63% | 39.77% | 60.22% | 44.44% | 3.1% | 41.75% | - | - | - | - | - | - | - | - | 3339.22% | 1370.32% | 1962.1% | 2020.69% | 401.8% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -200K | 1000K | -339K | -572K | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -3.21M | -838K | -1.01M | -1.67M | -1.46M | 502K | -1.13M | -1.38M | -1.62M | -1.79M | -6.01M | -1.86M | -3.27M | -4.46M | -4.52M | -13.43M | -12.98M | -14.34M | -11.29M | -16.18M |
| Operating Margin % | - | -81.76% | -114.97% | -1797.85% | -1798.77% | 27.8% | -581.44% | - | - | - | - | - | - | - | - | -4389.87% | -1826.16% | -2690.06% | -3242.82% | -539.2% |
| Operating Income Growth % | -120.25% | -266.93% | 10.82% | -20.81% | 9.95% | 127.97% | 81.25% | 25.79% | 50.6% | 59.71% | -33.13% | 86.12% | 74.78% | 68.93% | 59.96% | 16.96% | 3.07% | 25.42% | 48.19% | 17.77% |
| EBITDA | -3.21M | -838K | -976K | -1.67M | -1.46M | 502K | -1.13M | -1.38M | -1.62M | -1.78M | -6M | -1.85M | -3.26M | -4.46M | -4.41M | -13.42M | -12.94M | -14.29M | -11.24M | -16.06M |
| EBITDA Margin % | - | -81.76% | -111.54% | -1797.85% | -1798.77% | 27.8% | -581.44% | - | - | - | - | - | - | - | - | -4384.31% | -1819.41% | -2681.05% | -3229.02% | -535.27% |
| EBITDA Growth % | -120.25% | -266.93% | 13.48% | -20.81% | 9.95% | 128.22% | 81.2% | 25.14% | 50.35% | 60.07% | -36.12% | 86.22% | 74.81% | 68.82% | 60.78% | 16.45% | 1.53% | 23.8% | 46.98% | 15.75% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.25K | 16.25K | 16.25K | 16.25K | 0 | 0 | 17K | 48K | 48K | 48K | 118K |
| EBIT | -3.21M | -838K | -976K | -1.67M | -1.46M | 502K | -1.13M | -1.38M | -1.62M | -1.79M | -2.71M | -1.86M | -3.27M | -4.46M | -4.41M | -13.43M | -12.98M | -14.34M | -11.29M | -15.29M |
| Net Interest Income | 32K | 39K | 30K | 31K | 28K | 28K | 42K | 62K | 76K | 101K | 107K | 62K | 88K | 132K | 111K | 45K | 0 | -1K | -5K | -6K |
| Interest Income | 32K | 39K | 30K | 31K | 28K | 28K | 42K | 62K | 76K | 101K | 107K | 62K | 88K | 132K | 111K | 45K | - | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | - | 1K | 5K | 6K |
| Other Income/Expense | 32K | 39K | 30K | 1.35M | 28K | 28K | 405K | 62K | 76K | 101K | 107K | 62K | 88K | 132K | 111K | 45K | 6K | 3.56M | -5K | -6K |
| Pretax Income | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | -5.91M | -1.8M | -3.19M | -4.32M | -4.41M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M |
| Pretax Margin % | - | -77.95% | -111.54% | -348.39% | -1764.2% | 29.35% | -372.68% | - | - | - | - | - | - | - | - | -4375.16% | -1825.32% | -2021.58% | -3244.25% | -539.4% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | 7.57M | -4.18M | -6.95M | -7.22M | -10.5M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M |
| Net Margin % | - | -77.95% | -111.54% | -348.39% | -1764.2% | 29.35% | -372.68% | - | - | - | - | - | - | - | - | -4375.16% | -1825.32% | -2021.58% | -3244.25% | -539.4% |
| Net Income Growth % | -122.32% | -250.75% | -34.99% | 75.49% | 7.33% | 131.29% | -109.56% | 68.38% | 77.83% | 76.52% | 172.08% | 68.77% | 46.42% | 33.03% | 7.03% | 17.27% | 3.14% | 43.96% | 39.99% | 17.16% |
| Net Income (Continuing) | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | -5.91M | -1.8M | -3.19M | -4.32M | -4.41M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | -1000K | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.76 | -0.25 | -0.30 | -0.11 | -0.56 | 0.21 | -0.29 | -0.53 | -0.62 | -0.68 | -3.36 | -1.83 | -3.11 | -3.23 | -4.97 | -6.46 | -6.28 | -5.23 | -5.22 | -9.06 |
| EPS Growth % | -35.71% | -219.05% | -3.45% | 79.25% | 9.68% | 130.88% | 91.37% | 71.04% | 80.06% | 78.95% | 32.39% | 71.67% | 50.48% | 38.24% | 4.79% | 28.7% | 20.1% | 57.51% | 55.46% | 35.56% |
| EPS (Basic) | -0.76 | -0.25 | -0.30 | -0.11 | -0.56 | 0.21 | -0.29 | -0.53 | -0.62 | -0.68 | -3.36 | -1.83 | -3.11 | -3.23 | -4.97 | -6.46 | -6.28 | -5.23 | -5.22 | -9.06 |
| Diluted Shares Outstanding | 4.21M | 3.23M | 3.23M | 3.07M | 2.56M | 2.55M | 2.53M | 2.51M | 2.49M | 2.47M | 2.44M | 2.28M | 2.18M | 2.18M | 2.07M | 2.07M | 2.07M | 2.06M | 2.16M | 1.79M |
| Basic Shares Outstanding | 4.21M | 3.23M | 3.23M | 3.07M | 2.56M | 2.55M | 2.53M | 2.51M | 2.49M | 2.47M | 2.44M | 2.28M | 2.18M | 2.18M | 2.07M | 2.07M | 2.07M | 2.06M | 2.16M | 1.79M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |